Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
Li H et al. | 2005 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz | 0.4 mT |
Sanie-Jahromi F et al. | 2016 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 0.25–0.5 mT |
Dees C et al. | 1996 | intact cell/cell culture, MCF-7 and T-47D cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz, co-exposure | 1.2–900 µT |
Mousavi M et al. | 2014 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 0.04 T |
Mahmoudinasab H et al. | 2016 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) | magnetic field, 50/60 Hz | 0.25–0.5 mT |
Mahmoudinasab H et al. | 2016 | intact cell/cell culture, MCF-7 cells (human breast cancer cell line) | magnetic field, 50/60 Hz | 0.25–0.5 mT |
Lee HC et al. | 2015 | intact cell/cell culture, MCF10 A (human breast epithelial cell line), MCF7 (human breast cancer cell line), Jurkat cells (human lymphoblastoid T cell line), NIH3T3 (mouse embryonic fibroblast cell line) | magnetic field, 50/60 Hz | 0.1–2 mT |
Lazzarini R et al. | 2023 | intact cell/cell culture, MDA-MB-231 cells (breast cancer cell line) and MDA-MB-231 (human breast cell line) | magnetic field, 50/60 Hz | - |
Domínguez G et al. | 2021 | intact cell/cell culture, MDCK cells (Madin-Darby canine kidney cell line) | magnetic field, 50/60 Hz | 1–5 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.